These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9825105)

  • 21. Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial.
    Graham DR; Talan DA; Nichols RL; Lucasti C; Corrado M; Morgan N; Fowler CL
    Clin Infect Dis; 2002 Aug; 35(4):381-9. PubMed ID: 12145720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amoxicillin/clavulanic acid (875/125 mg). New pharmacodynamic aspects].
    Lode H
    Dtsch Med Wochenschr; 1999 Dec; 124(48):1459-61. PubMed ID: 10615328
    [No Abstract]   [Full Text] [Related]  

  • 23. [Efficacy and tolerance of coamoxiclav in community-acquired lower respiratory tract infections in children].
    Blokhin BM; Aldonina VV; Kozhukhova TM; Nikulin LA; Rumyantsev AG
    Antibiot Khimioter; 1997; 42(10):29-32. PubMed ID: 9412400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
    Belliveau P; Nightingale CH; Quintiliani R; Crowe H; Gousee G
    Conn Med; 1993 Aug; 57(8):539-45. PubMed ID: 8243083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections.
    Kosmidis J
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():73-9. PubMed ID: 1664832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae.
    Berry V; Hoover J; Singley C; Woodnutt G
    Antimicrob Agents Chemother; 2005 Mar; 49(3):908-15. PubMed ID: 15728883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of ciprofloxacin in the treatment of hospital infections of the lower respiratory tract].
    Chuchalin AG; Novikov IuK; Avdeev SN; Belevskiĭ AS
    Antibiot Khimioter; 1997; 42(6):34-8. PubMed ID: 9313057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of cefaclor vs. amoxicillin/clavulanate in tonsillopharyngitis.
    Haczyński J; Bardadin J; Gryczyńska D; Gryczyński M; Gołabek W; Kawalski H; Kaźmierczak H; Krecicki T; Kubik P; Namysłowski G; Popiel L
    Med Sci Monit; 2001; 7(5):1016-22. PubMed ID: 11535952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
    Sader HS; Jacobs MR; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):5S-12S. PubMed ID: 17292577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial.
    Khajotia RR; Vetter N; Harazin H
    Clin Ther; 1991; 13(4):460-6. PubMed ID: 1933997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous followed by oral ofloxacin in the treatment of community acquired lower respiratory tract infections in adults requiring hospitalisation.
    Liam CK; Aziah AM; Lim KH; Wong CM
    Med J Malaysia; 2000 Sep; 55(3):304-7. PubMed ID: 11200708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sensitivity of urogenital aerobic microflora to antibiotics].
    Sirokvasha EA; Krysenko AV; Skliar TV; Vinnikov AI
    Mikrobiol Z; 2001; 63(5):75-9. PubMed ID: 11785424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
    Savitskaia KI; Trapeznikova MF; Nekhorosheva AG; Solodilova OE; Nasonov VN; Dutov VV; Kalinin VN; Shanina AG; Rusanova EV
    Klin Med (Mosk); 1994; 72(2):38-42. PubMed ID: 8015241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of acute respiratory tract diseases in cattle with Bisolvon in combination with either enrofloxacin, cefquinome, ceftiofur or florfenicol].
    Schmidt H; Philipp H; Hamel U; Quirke JF
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 1998 May; 26(3):127-32. PubMed ID: 9646401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): comparative pharmacokinetics and the role of therapeutic drug monitoring.
    Pea F; Milaneschi R; Baraldo M; Lugatti E; Talmassons G; Furlanut M
    Ther Drug Monit; 2000 Aug; 22(4):386-91. PubMed ID: 10942176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Coamoxiclav in the empirical monotherapy in outpatients with community acquired pneumonia].
    Yakovlev SV; Leshchenko IV; Kolesnikov VV; Suvorova MP
    Antibiot Khimioter; 1997; 42(10):19-22. PubMed ID: 9412398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of fluoroquinolones in rheumatology].
    Belov BS; Shubin SV; Nasonova VA; Soldatova SI; Tarasova GM; Urumova MM; Ushakova MA; Anan'eva LP
    Vestn Ross Akad Med Nauk; 1996; (12):12-5. PubMed ID: 9102072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ten-year experience with the use of ofloxacin in the treatment of wound infection].
    Blatun LA; Iakovlev VP; Svetukhin AM; Puchkova LS; Izotova GN
    Antibiot Khimioter; 1996; 41(9):73-6. PubMed ID: 9005792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.